Genkyotex
Genkyotex is a biopharmaceutical company that develops and commercializes NOX therapies for fibrosis, inflammation and cancer diseases.
Business Model:
Revenue: $908.2k
Employees: 11-50
Rankings
Industries / Tags:
Detailed Genkyotex Information
Genkyotex was acquired by
Calliditas Therapeutics.
The acquisition happend on 2020-08-13.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Forum 2 Archamps Technopole 218 Marie Curie Avenue
City: Saint-Julien-en-Genevois
State: auvergne
Zip: 74166
Country: FR
Financial Info
Stage:
post ipo equity
Raised Last:
$5M
Raised Total:$49M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Genkyotex is a biopharmaceutical company that develops and commercializes NOX therapies for fibrosis, inflammation and cancer diseases.
Contact Phone:
Contact Email:
Genkyotex went public on 4/11/2014 on the PA
Listed Exchange:
PA
IPO Date:
4/11/2014
Ticker Symbol:
Paris:GKTX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 2/2017 | Genticel |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
